Apply Now to The Susan Skinner Memorial Fund Scholarship: Advancing Women’s Leadership in the Bleeding Disorders Field
The World Federation of Hemophilia (WFH) recently shared an announcement post on X:
”Applications for The Susan Skinner Memorial Fund scholarship program is now open! The scholarship encourages the active participation of women of all ages in the global Bleeding Disorders community through education, training and networking.”
To learn more, follow the link.
The Susan Skinner Memorial Fund scholarship supports the leadership and active engagement of women aged 18 to 60 within the global bleeding disorders community.
Awarded every two years to both U.S. and international applicants, the scholarship provides opportunities for education, training, and networking at major WFH events.
This year’s recipients will attend the WFH 2026 World Congress in Kuala Lumpur, gaining invaluable experience and connections to advance advocacy and care in inherited bleeding disorders.
The project aims to enhance the treatment and care for women and girls with bleeding disorders (WGBD) across local, national, and global communities.
Applications are now open for this transformative program and will be accepted from July 15 to September 15, 2025.
Do not miss the chance!
Discover more global scholarship opportunities in Hemostasis Today.
-
Jul 16, 2025, 17:23ISTH 2025 Spotlight: HOPE-B Trial Highlights Sustained Efficacy of Gene Therapy for Hemophilia B
-
Jul 16, 2025, 15:00Together with Dr. Bethany Samuelson Bannow – Let’s Keep Hematology Moving Forward
-
Jul 16, 2025, 14:58Donate Today to Advance Thrombosis Awareness and Research
-
Jul 16, 2025, 14:57ISTH SSC Launches Survey on Antithrombotic Therapy in Brain Tumor Patients
-
Jul 16, 2025, 14:52ASH Expands Access to Educational Resources in LMICs
-
Jul 16, 2025, 11:06Why Pain Feels Different for Everyone - The Guardian
-
Jul 15, 2025, 18:24Time and Severe Hypoperfusion: 2 Threats for Hemorrhagic Transformation in Stroke
-
Jul 15, 2025, 15:48Managing CVT in Pregnancy: Balancing Risks and the Role of Antithrombotic Prophylaxis
-
Jul 15, 2025, 07:37Triple Therapy Breakthrough: Corticosteroids, IVIG, and Platelet Transfusions Transform Management of Critical ITP Bleeding - Blood Journals Portfolio
-
Jul 14, 2025, 18:253 Valuable Takeaways from the ANGEL-REBOOT Trial for ICAS-O Stroke
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 15, 2025, 17:002022 Chemistry Laureate Carolyn Bertozzi Shares Inspiring Advice for Young Scientists
-
Jul 15, 2025, 16:42A 200+ Year Historical Review of Women and Hemophilia: Shifting Perspectives
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems